Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Connect Biopharma Holdings Limited - American Depositary Shares (NQ:CNTB)

0.6306 +0.0006 (+0.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,000
Open 0.6306
Bid (Size) 0.6487 (1)
Ask (Size) 0.7399 (1)
Prev. Close 0.6300
Today's Range 0.6306 - 0.6306
52wk Range 0.5500 - 2.660
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma
From Connect Biopharma Holdings Limited
Via GlobeNewswire

Performance

YTD
-47.9%
-47.9%
1 Month
-27.7%
-27.7%
3 Month
-47.9%
-47.9%
6 Month
-56.6%
-56.6%
1 Year
-69.7%
-69.7%

More News

Read More
Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Connect Biopharma Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Connect Biopharma to Present at Two Upcoming Investor Conferences
From Connect Biopharma Holdings Limited
Via GlobeNewswire
David Szekeres, President of Connect Biopharma Holdings Limited (NASDAQ: CNTB), to Present at NobleCon20
Via Investor Brand Network
Attovia Therapeutics Appoints Chief Financial Officer
From Attovia Therapeutics, Inc.
Via GlobeNewswire
Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Week In Review: EpimAb Sells T-Cell Engager In $635 Million Deal
Via Talk Markets
Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum
From Connect Biopharma Holdings Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Connect Biopharma Announces New Leadership and Chair of the Board of Directors
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
From Connect Biopharma Holdings Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference
From Connect Biopharma Holdings Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
From Connect Biopharma Holdings Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Week in Review: SystImmune Out-Licenses Global Rights for ADC to BMS in $8.4 Billion Deal
Via Talk Markets

Frequently Asked Questions

Is Connect Biopharma Holdings Limited - American Depositary Shares publicly traded?
Yes, Connect Biopharma Holdings Limited - American Depositary Shares is publicly traded.
What exchange does Connect Biopharma Holdings Limited - American Depositary Shares trade on?
Connect Biopharma Holdings Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Connect Biopharma Holdings Limited - American Depositary Shares?
The ticker symbol for Connect Biopharma Holdings Limited - American Depositary Shares is CNTB on the Nasdaq Stock Market
What is the current price of Connect Biopharma Holdings Limited - American Depositary Shares?
The current price of Connect Biopharma Holdings Limited - American Depositary Shares is 0.6306
When was Connect Biopharma Holdings Limited - American Depositary Shares last traded?
The last trade of Connect Biopharma Holdings Limited - American Depositary Shares was at 04/02/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.